Enli Liu, MD, MS1*, Yijiu Tong1*, Gianpietro Dotti, MD2*, Barbara Savoldo, MD2*, Muharrem Muftuoglu1*, Kayo Kondo, PhD1*, Malini Mukherjee3*, Jordan S. Orange, MD, PhD4*, Catherine Sobieski1*, Abdullah Alsuliman1*, Hila Shaim, MD1*, Nobuhiko Imahashi, MD, PhD1*, Michael J. Keating, MD5, Chitra M. Hosing, MD1, Nina Shah, MD1, William Wierda, MD, PhD6, Richard Champlin, MD1, Elizabeth J. Shpall, MD1 and Katayoun Rezvani, MD PhD1
1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Baylor College of Medicine, Center for Cell and Gene Therapy, Houston, TX
3Pediatrics-Human Immunobiology, Baylor College of Medicine, Houston, TX
4Center for Human Immunobiology, Texas Children's Hospital and Baylor College of Medicine, Houston, TX
5Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX